Also trades as: HAVN.CN (CNQ) · $vol 0M
HAVLF OTC
HAVN Life Sciences Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.5%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.00001-0.01
Volume22,105
Avg Volume20,435
Beta-0.30
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOTim Moore
Employees6
SectorHealthcare
IndustryBiotechnology
IPO Date2021-01-08
Websitehavnlife.com
605 - 130 Brew Street
Port Moody, BC V3H 0E3
CA
Port Moody, BC V3H 0E3
CA
604-687-7130
About HAVN Life Sciences Inc.
HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms. The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroom species and their key constituents such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health products utilizing unregulated ingredients. Founded in 2020, HAVN Life Sciences' operations are headquartered in Richmond, Canada.
Latest News
No recent news
Recent Insider Trades
No insider trades found